期刊文献+

代谢综合征与大肠腺瘤的相关性研究 被引量:3

Study of the relationship between metabolic syndrome and colorectal adenoma
原文传递
导出
摘要 目的研究代谢综合征(MS)与大肠腺瘤的相关性。方法选取2009年6月~2012年6月所有接受结肠镜检查的患者,根据排除标准及肠镜检查结果诊断大肠腺瘤组455例,同时选取同期年龄匹配,肠镜结果未见异常的体检者455例为对照组。所有研究对象均检查空腹血糖、血脂,并测量血压、腰围,记录肠镜下腺瘤分布部位、大小、病理结果。对大肠腺瘤组与对照组各临床参数进行比较,运用Logistic回归分析代谢综合征与大肠腺瘤的相关性。结果(1)大肠腺瘤组代谢综合征患病率高于对照组(P〈0.01),代谢综合征及血糖异常是大肠腺瘤的独立危险因素;(2)代谢综合征病种数量在个体聚集越多,患大肠腺瘤可能性越大;(3)大肠腺瘤合并代谢综合征患者大肠腺瘤数目多为3个或以上,大小为5~9mm,病理多呈进展性改变。结论代谢综合征与大肠腺瘤密切相关,尽早对代谢综合征患者行结肠镜检查,有利于大肠腺瘤的防治。 Objective To explore the relationship between metabolic syndrome (MS) and color- ectal adenoma(CRA). Methods All cases who received colonoscopy from Jun,2009 to Jun,2012 in our hospital were divided into CRA group( n = 455) and matched controls( n = 455). The diagnosis of CRA is based on the exclusion criteria and colonoscopy examination. Blood glucose, blood lipids, blood pressure, waist circumference,weight, height and blood uric acid were measured. The characteristics of CRA were recorded, and the clinical features between CRA and control group were compared. Logistic regression was used to analyze the association between MS and CRA. Results The morbility rate of MS in CRA group was significantly higher than that in the control group( P 〈0.01 ). MS and abnormal blood glucose were in- dependent risk factors for CRA. The incidence of CRA increased with the clustering components of MS. In CRA patients with MS,those CRA with number of multiple(≥3 ) or with size of 5-9 mm(diameter) usu- ally have progressive biopsy change. Conclusion MS is associated with CRA. The patient with MS should accept colonoscopy earlier,which is benefit for the prevention and treatment of CRA.
出处 《临床内科杂志》 CAS 2012年第12期824-826,共3页 Journal of Clinical Internal Medicine
关键词 大肠腺瘤 代谢综合征 胰岛素抵抗 危险因素 Colorectal adenoma Metabolic syndrome Insulin resistance Risk factor
  • 相关文献

参考文献14

  • 1Morita T,Tabata S, Mineshita M, et al. The metabolic syndrome is asso- ciated with increased risk of colorectal adenoma development:the Self- Defense Forces health study. Asian Pac J Cancer Prey, 2005, 6: 485-489.
  • 2Kim KS,Moon HJ, Choi CH, et al. The Frequency and Risk Factors of Colorectal Adenoma in Health-Check-up Subjects in South Korea:Rela- tionship to Abdominal Obesity and Age. Gut Liver,2010,4:36-42.
  • 3Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005,112:2735-2752.
  • 4Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroen- terology,2007,132:2208-2225.
  • 5Sben Z, Wang S,Ye Y, et al. Clinical study on the correlation between metabolic syndrome and colorectal carcinoma. ANZ J Surg,2010,80: 331-336.
  • 6Giovannueei E. Metabolic syndrome, hyperinsulinemia, and colon eanc- er:a review. Am J Clin Nutr,2007,86 :s836-842.
  • 7欧希龙,孙为豪,曹大中,俞谦,俞婷,张有珍,吴志英.27例大肠息肉癌变肠镜特点及诊治[J].中国内镜杂志,2005,11(8):804-806. 被引量:26
  • 8Citarda F,Tomaselli G, Capoeaccia R, et al. Efficacy in standard clini- cal practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut, 2001,48 : 812 -815.
  • 9Tsilidis KK, Brancati FL, Pollak MN,et al. Metabolic syndrome compo- nents and colorectal adenoma in the CLUE II cohort. Cancer Causes Control,2010,21 : 1-10.
  • 10吴礼浩,谢文瑞,蔡洁毅,马伟钦,何兴祥,聂玉强.代谢综合征与大肠腺瘤相关性研究[J].河北医学,2011,17(10):1281-1284. 被引量:6

二级参考文献20

  • 1冯福才,张亚历.大肠息肉癌变及内镜处理[J].中国实用内科杂志,1996,16(7):390-392. 被引量:17
  • 2Calle EE,Rodriguez C,Walker-Thurmond K,Than MJ.Overweight,obesity and mortality from cancer in a prospectively studied cohort of U S.adults[J].N Engl Med,2003,348:1625-1638.
  • 3Lukanova A,Bjor O,Kaaks R,et al.Body mass index and cancer:results from the Northern Sweden Health and Disease Cohort[J].Int Cancer,2006,118:458-466.
  • 4Calle EE,Bodriguez C,Walker-Thurmond K,et al.Overweight,obesity and mortality from cancer in a prospectively studied cohort of U S.adults[J].N Engl,Med,2003,348:1625-1638.
  • 5Murphy TK,Calle EE,Rodriguez C,et al.Body mass index and colon cancer morality in a large prospective study[J].Am Epidemiol,2000,152:847-854.
  • 6Will JC,Galuska DA,Vinicor F,et al.Colorectal cancer:another complication of diabetes mellitus[J].Am Epidemid,1998,147:816-825.
  • 7Chiu HM,Lin JT,Chen TH,et al.Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men[J].Am Gastroenterol,2008,103(9):2317-2325.
  • 8Erlinger TP,Platz EA,Rifai N,et al.C-reactive protein and the risk of incident colorectal cancer[J].JAMA,2004,291 (5):585-590.
  • 9Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart,Lung and Blood Institute Scientific Statement[J].Circulation,2005,112 (17):2735-2752.
  • 10Levin B,Brooks D,Smith RA,et al.Emerging technologies in screening for colorectal cancer:CT colonography,immunochemical fecal occult blood tests,stool screening using molecular markers[J].CA Cancer Clin,2003,53:44-55.

共引文献30

同被引文献21

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部